(NBC) After coming under fire for increased prices of he drug Daraprim, which helps prevent malaria and treats toxoplasmosis, and infection caused by a parasite, by more than five thousand percent the CEO of the pharmaceutical company responsible for the increase says he will now lower the cost of the medication.
Pharmaceutical CEO Martin Shkreli says his decision absolutely has to do with the outrage over the increasing of the drug. The price went from $13.50 to $750 per pill.
The reason for the increase? Shkreli says it would have been used to develop a better treatment with fewer side effects.
There has been no word on what the new price of the drug will be but Shkreli says he’ll lower the price to either break even or make a smaller profit.